Abstract
Inbred mice have provided the majority of knowledge regarding the pathogenesis of lupus. Their ease of use relates predominately to their more accessible immune organs, greater genetic homogeneity, and more predictable disease manifestations compared to humans. Many mouse strains develop lupus-like symptoms and signs, but the best studied include BXSB/Mp, (NZB × NZW)F1 and its derivative NZM, (NZB × SWR)Fl, and the congenic strains MRL/Mp and MRL/Mplpr/lpr (MRL/lpr) (1). Many studies have used the latter strain, which lacks functional activity of the CD95 (Fas) apoptosis antigen (2,3), a significant regulator of activated T and B cells (4–8); hence, its designation MRL/Faslpr. Consequently, extrapolations of conclusions to systemic lupus erythematosus (SLE) in general must bear in mind the CD95 phenotype of 1pr animals, which possess severe defects in T- and B-cell tolerance (9–14), and which accumulate large numbers of T cells unable to undergo Fas-induced cell death after activation. Nevertheless, such animals with known genetic alterations provide substantially increased insight into the lupus immune system by allowing an examination of disease manifestations in the setting of known immune deficiencies and/or transgenes. Indeed, the availability of efficient genetic modification provides yet another advantage to the study of lupus in the murine system. This chapter highlights several studies in genetically manipulated lupus-prone mice, with particular attention to implications for human disease pathogenesis (Tables 1-3).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Wallace, D. J. and Hahn, B. H. (1997). Dubois’ Lupus Erythematosus, Williams and Wilkins, Baltimore.
Watanabe-Fukunaga, R., Brannan, C. I., Copeland, N. G., Jenkins, N. A., and Nagata, S. (1992) Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356, 314–317.
Wu, J., Zhou, T., Zhang, J., He, J., Gause, W. C., and Mountz, J. D. (1994) Correction of accelerated autoimmune disease by early replacement of the mutated 1pr gene with the normal Fas apoptosis gene in the T cells of transgenic MRL-1pr/lpr mice. Proc. Natl. Acad. Sci. USA 91, 2344–2348.
Brunner, T., Mogil, R. J., LaFace, D., Yoo, N. J., Mahboubi, A., Echeverri, F., Martin, S. J., Force, W. R., Lynch, D. H., Ware, C. F., and Green, D. R. (1995) Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 373, 441–444.
Dhein, J., Walczak, H., Baumler, C., Debatin, K. M., and Krammer, P. H. (1995) Autocrine T-cell suicide mediated by APO-1/(Fas/CD95) Nature 373, 438–441.
Ju, S. T., Panka, D. J., Cui, H., Ettinger, R., el Khatib, M., Sherr, D. H., Stanger, B. Z., and Marshak-Rothstein, A. (1995) Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 373, 444–448.
Rathmell, J. C., Cooke, M. P., Ho, W. Y., Grein, J., Townsend, S. E., Davis, M. M., and Goodnow, C. C. (1995) CD95 (Fas)-dependent elimination of self-reactive B cells upon interaction with CD4+ T cells. Nature 376, 181–184.
Rothstein, T. L., Wang, J. K., Panka, D. J., Foote, L. C., Wang, Z., Stanger, B., Cui, H., Ju, S. T., and Marshak-Rothstein, A. (1995) Protection against Fas-dependent Th1-mediated apoptosis by antigen receptor engagement in B cells. Nature 374, 163–165.
Rathmell, J. C. and Goodnow, C. C. (1994) Effects of the 1pr mutation on elimination and inactivation of self-reactive B cells. J. Immunol. 153, 2831–2842.
Singer, G. G. and Abbas, A. K. (1994) The fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T-cell receptor transgenic mice. Immunity 1, 365–371.
Roark, J. H., Kuntz, C. L., Nguyen, K. A., Mandik, L., Cattermole, M., and Erikson, J. (1995) B cell selection and allelic exclusion of an anti-DNA Ig transgene in MRL-1pr/lpr mice. J. Immunol. 154, 4444–4455.
Roark, J. H., Kuntz, C. L., Nguyen, K. A., Caton, A. J., and Erikson, J. (1995) Breakdown of B cell tolerance in a mouse model of systemic lupus erythematosus. J. Exp. Med. 181, 1157–1167.
Rubio, C. F., Kench, J., Russell, D. M., Yawger, R., and Nemazee, D. (1996) Analysis of central B cell tolerance in autoimmune-prone MRL/lpr mice bearing autoantibody trans-genes. J. Immunol. 157, 65–71.
Sytwu, H. K., Liblau, R. S., and McDevitt, H. O. (1996) The roles of Fas/APO-1 (CD95) and TNF in antigen-induced programmed cell death in T-cell receptor transgenic mice. Immunity 5, 17–30.
Holman, H. R., and Kunkel, H. G. (1957) Affinity between the lupus erythematosus serum factor and cell nuclei and nucleoprotein. Science 126, 162–164.
Tan, E. M., and Kunkel, H. G. (1966) Characteristics of a soluble nuclear antigen precipitating with sera of patients with systemic lupus erythematosus. J. Immunol. 96, 464–471.
Hardin, J. A. (1986) The lupus autoantigens and the pathogenesis of systemic lupus erythematosus. Arthritis Rheum. 29, 457–460.
Shoenfeld, Y., and George, J. (1997) Induction of autoimmunity• a role for the idiotypic network. Ann. N YAcad. Sci. 815, 342–349.
Casciola-Rosen, L. A., Anhalt, G. J., and Rosen, A. (1995) DNA-dependent protein kinase is one of a subset of autoantigens specifically cleaved early during apoptosis. J. Exp. Med. 182, 1625–1634.
Shlomchik, M. J., Marshak-Rothstein, A., Wolfowicz, C. B., Rothstein, T. L., and Weigert, M. G. (1987) The role of clonal selection and somatic mutation in autoimmunity Nature 328, 805–811.
Fatenejad, S., Mamula, M., and Craft, J. (1993) Role of intermolecular/intrastructural B- and T-cell determinants in the diversification of autoantibodies to ribonucleoprotein particles. Proc. Natl. Acad. Sci. USA 90, 12,010–12, 014.
Theofilopoulos, A. N. (1982) Role of the thymus in murine lupus and cellular transfer of the disease. Arthritis Rheum. 25, 726–733.
Ikehara, S., Good, R. A., Nakamura, T., Sekita, K., Inoue, S., Oo, M. M., Muso, E., Ogawa, K., and Hamashima, Y. (1985) Rationale for bone marrow transplantation in the treatment of autoimmune diseases. Proc. Natl. Acad. Sci. USA 82, 2483–2487.
Sobel, E. S., Kakkanaiah, V. N., Kakkanaiah, M., Cheek, R. L., Cohen, P. L., and Eisenberg, R. A. (1994) T-B collaboration for autoantibody production in 1pr mice is cognate and MHC-restricted. J. Immunol. 152, 6011–6016.
Steinberg, A. D., Roths, J. B., Murphy, E. D., Steinberg, R. T., and Raveche, E. S. (1980) Effects of thymectomy or androgen administration upon the autoimmune disease of MRL/Mplprllpr mice. J. Immunol. 125, 871–873.
Wofsy, D. (1986) Administration of monoclonal anti-T-cell antibodies retards murine lupus in BXSB mice. J. Immunol. 136, 4554–4560.
Sainis, K. and Datta, S. K. (1988) CD4+ T-cell lines with selective patterns of autoreactivity as well as CD4- CD8- T helper cell lines augment the production of idiotypes shared by pathogenic anti-DNA autoantibodies in the NZB x SWR model of lupus nephritis. J. Immunol. 140, 2215–2224.
Mohan, C., Adams, S, Stanik, V., and Datta, S. K. (1993) Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus. J. Exp. Med. 177, 1367–1381.
Craft, J., and Fatenejad, S. (1997) Self antigens and epitope spreading in systemic autoimmunity. Arthritis Rheum. 40, 1374–1382.
Jevnikar, A. M., Grusby, M. J., and Glimcher, L. H. (1994) Prevention of nephritis in major histocompatibility complex class II-deficient MRL-lpr mice. J. Exp. Med. 179, 1137–1143.
Mohan, C., Shi, Y., Laman, J. D., and Datta, S. K. (1995) Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis. J. Immunol. 154, 1470–1480.
Desai-Mehta, A., Lu, L., Ramsey-Goldman, R., and Datta, S. K. (1996) Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production. J. Clin. Invest. 97, 2063–2073.
Early, G. S., Zhao, W., and Burns, C. M. (1996) Anti-CD40 ligand antibody treatment prevents the development of lupus-like nephritis in a subset of New Zealand black x New Zealand white mice: response correlates with the absence of an anti-antibody response. J. Immunol. 157, 3159–3164.
Koshy, M., Berger, D., and Crow, M. K. (1996) Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes. J. Clin. Invest. 98, 826–837.
Ma, J., Xu, J., Madaio, M. P., Peng, Q., Zhang, J., Grewal, L. S., Flavell, R. A., and Craft, J. (1996) Autoimmune 1pr/lpr mice deficient in CD40 ligand: spontaneous Ig class switching with dichotomy of autoantibody responses. J. Immunol. 157, 417–426.
Shan, H., Shlomchik, M. J., Marshak-Rothstein, A., Pisetsky, D. S., Litwin, S., and Weigert, M. G. (1994) The mechanism of autoantibody production in an autoimmune MRL/lpr mouse. J. Immunol. 153: 5104–5120.
Kotzin, B. L. (1996) Systemic lupus erythematosus. Cell 85, 303–306.
Hoffman, R. W., Takeda, Y., Sharp, G. C., Lee, D. R., Hill, D. L., Kaneoka, H., and Caldwell, C. W. (1993) Human T-cell clones reactive against U-small nuclear ribonucleoprotein autoantigens from connective tissue disease patients and healthy individuals. J. Immunol. 151, 6460–6469.
Okubo, M., Yamamoto, K., Kato, T., Matsuura, N., Nishimaki, T., Kasukawa, R., Ito, K., Mizushima, Y., and Nishioka, K. (1993) Detection and epitope analysis of autoantigen-reactive T cells to the U1-small nuclear ribonucleoprotein A protein in autoimmune disease patients. J. Immunol. 151, 1108–1115.
Creech, E. A., Nakul-Aquaronne, D., Reap, E. A., Cheek, R. L., Wolthusen, P. A., Cohen, P. L., and Eisenberg, R. A. (1996) MHC genes modify systemic autoimmune disease. J. Immunol. 156, 812–817.
Iwamoto, M., Ibnou-Zekri, N., Araki, K., and Izui, S. (1996) Prevention of murine lupus by an I-E a chain transgene: protective role of I-E a chain-derived peptides with a high affinity to I-Ab molecules. Eur. J. Immunol. 26, 307–314.
Perkins, D. L., Listman, J. A., Marshak-Rothstein, A., Kozlow, W., Kelley, V. R., Finn, P. W., and Rimm, I. J. (1996) Restriction of the TCR repertoire inhibits the development of memory T cells and prevents autoimmunity in 1pr mice. J. Immunol. 156, 4961–4968.
Mountz, J. D., Zhou, T., Eldridge, J., Berry, K., and Bluthmann, H. (1990) Transgenic rearranged T-cell receptor gene inhibits lymphadenopathy and accumulation of CD4–CD8B220+ T cells in 1pr/lpr mice. J. Exp. Med. 172, 1805–1817.
Sidman, C. L., Marshall, J. D., and Von Boehmer, H. (1992) Transgenic T-cell receptor interactions in the lymphoproliferative and autoimmune syndromes of 1pr and gld mutant mice. Eur. J. Immunol. 22, 499–504.
Padovan, E., Giachino, C., Cella, M., Valitutti, S., Acuto, O., and Lanzavecchia, A. (1995) Normal T lymphocytes can express two different T-cell receptor 13 chains: implications for the mechanism of allelic exclusion. J. Exp. Med. 181, 1587–1591.
Davodeau, F., Peyrat, M. A., Romagne, F., Necker, A., Hallet, M. M., Vie, H., and Bonneville, M. (1995) Dual T-cell receptor [3 chain expression on human T lymphocytes. J. Exp. Med. 181, 1391–1398.
Rajagopalan, S., Zordan, T., Tsokos, G. C., and Datta, S. K. (1990) Pathogenic anti-DNA autoantibody-inducing T helper cell lines from patients with active lupus nephritis: isolation of CD4–8- T helper cell lines that express the yS T-cell antigen receptor. Proc. Natl. Acad. Sci. USA 87, 7020–7024.
Koh, D.-R., Ho, A., Rahemutulla, A., Fung-Leung, W.-P., Griesser, H., and Mak, T.-W. (1995) Murine lupus in MRL/lpr mice lacking CD4 or CD8 T cells. Eur. J. Immunol. 25, 2558–2562.
Mixter, P. F., Russell, J. Q., Durie, J. H., and Budd, R. C. (1995) Decreased CD4–CD8TCR-a(3+ cells in 1prllpr mice lacking 32-microglobulin. J. Immunol. 154, 2063–2074.
Ohteki, T., Iwamoto, M., Izui, S., and MacDonald, H. R. (1995) Reduced development of CD4–8-B220+ T cells but normal autoantibody production in 1pr/ipr mice lacking major histocompatibility complex class I molecules. Eur. J. Immunol. 25, 37–41.
Geise, T. and Davidson, W. F. (1995) In CD8+ T-cell-deficient 1prllpr mice, CD4+B220+ and CD4+B220- T cells replace B220+ double-negative T cells as the predominant populations in enlarged lymph nodes. J. Immunol. 154, 373, 4986–4995.
Maldonado, M. A., Eisenberg, R. A., Roper, E., Cohen, P. L., and Kotzin, B. L. (1995) Greatly reduced lymphoproliferation in 1pr mice lacking major histocompatibility complex class I. J. Exp. Med. 181, 641–648.
Christianson, G. J., Blankenburg, R. L., Duffy, T. M., Panka, D., Roths, J. B., MarshakRothstein, A., and Roopenian, D. C. (1996) (32- microglobulin dependence of the lupus-like autoimmune syndrome of MRL-/pr mice. J. Immunol. 156, 4932–4939.
Tsao, B. P., Ohnishi, K., Cheroutre, H., Mitchell, B., Teitell, M., Mixter, P., Kronenberg, M., and Hahn, B. H. (1992) Failed self-tolerance and autoimmunity in IgG anti-DNA transgenic mice. J. Immunol. 149, 350–358.
Shlomchik, M. J., Madaio, M. P., Ni, D., Trounstein, M., and Huszar, D. (1994) The role of B cells in 1prllpr-induced autoimmunity. J. Exp. Med. 180, 1295–1306.
Radic, M. Z., Ibrahim, S. M., Rauch, J., Camper, S. A., and Weigert, M. (1995) Constitutive secretion of transgene-encoded IgG2b autoantibodies leads to symptoms of autoimmune disease. J. Immunol. 155, 3213–3222.
Chan, O., and Shlomchik, M. J. (1998) A new role of B cells in systemic autoimmunity. B cells promote spontaneous T-cell activation in MRL-1prllpr mice. J. Immunol. 160, 51–59.
Goodnow, C. C., Crosbie, J., Adelstein, S., Lavoie, T. B., Smith-Gill, S. J., Brink, R. A., Pritchard-Briscoe, H., Wotherspoon, J. S., Loblay, K. Raphael, R. H., Trent, R. J., and Basten, A. (1988) Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature 334, 676–682.
Nemazee, D. A., and Bürki, K. (1989) Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes. Nature 337, 562–566.
Offen, D., Spatz, L., Escowitz, H., Factor, S., and Diamond, B. (1992) Induction of tolerance to an IgG autoantibody. Proc. Natl. Acad. Sci. USA 89, 8332–8336.
Tighe, H., Chen, P. P., Tucker, R., Kipps, T. J., Roudier, J., Jirik, F. R., and Carson, D. A. (1993) Function of B cells expressing a human immunoglobulin M rheumatoid factor autoantibody in transgenic mice. J. Exp. Med. 177, 109–118.
Fisher, G. H., Rosenberg, F. J., Straus, S. E., Dale, J. K., Middleton, L. A., Lin, A. Y., Strober, W., Lenardo, M. J., and Puck, J. M. (1995) Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81, 935–946.
Rieux-Laucat, F., Deist, F. L., Hivroz, C., Roberts, I. A. G., Debatin, K. M., Fischer, A., and Villartay, J. P. D. (1995) Mutations in fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268, 1347–1349.
Wu, J., Wilson, J., He, J., Xiang, L. Schur, P., and Mountz, J. D. (1996) Fas ligand mutation in a patient with systemic lupus erythematosus and lymproproliferative disease. J. Clin. Invest. 98, 1107–1113.
Jacobson, B. A., Panka, D. J., Nguyen, K.-A., Erikson, J., Abbas, A. K., and Marshak-Rothstein, A. (1995) Anatomy of autoantibody production: dominant localization of antibody-producing cells to T-cell zones in Fas-deficient mice. Immunity 3, 509–519.
Mandik-Nayak, L., Bui, A., Noorchashm, H., Eaton, A., and Erikson, J. (1997) Regulation of anti-double-stranded DNA B cells in nonautoimmune mice: localization to the T-B interface of the splenic follicle. J. Exp. Med. 186, 1257–1267.
Radic, M. Z., Erikson, J., Litwin, S., and Weigert, M. (1993) B lymphocytes may escape tolerance by revising their antigen receptors. J. Exp. Med. 177, 1165–1173.
Iliev, A., Spatz, L., Ray, S., and Diamond, B. (1994) Lack of allelic exclusion permits autoreactive B cells to escape deletion. J. Immunol. 153, 3551–3556.
Chen, C., Nagy, Z., Radic, M. Z., Hardy, R., R., Huszar, D., Camper, S. A., and Weigert, M. (1995) The site and stage of anti-DNA B-cell deletion. Nature 373, 252–255.
Cyster, J G., Hartley, S. B., and Goodnow, C. C. (1994) Competition for follicular niches excludes self-reactive cells from the recirculating B-cell repertoire. Nature 371, 389–395.
Cornall, R. J., Goodnow, C. C., and Cyster, J. G. (1995) The regulation of self-reactive B cells. Curr. Opin. Immunol. 7, 804–811.
Tighe, H., Warnatz, K., Brinson, D., Corr, M., Weigle, W. O., Baird, S. M., and Carson, D. A. (1997) Peripheral deletion of rheumatoid factor B cells after abortive activation by IgG. Proc. Natl. Acad. Sci. USA 94, 646–651.
Klinman, D. M., and Steinberg, A. D. (1987) Systemic autoimmune disease arises from polyclonal B cell activation. J. Exp. Med. 165, 1755–1760.
Klinman, D. M., and Steinberg, A. D. (1995) Inquiry into murine and human lupus. Immunol. Rev. 144, 157–193.
DesJardin, L. E., Butfiloski, E. J., Sobel, E. S., and Schiffenbauer, J. (1996) Hyperproliferation of BXSB B cells is linked to the Yaa allele. Clin. Immunol. Immunopathol. 81, 145–152.
Peng, S. L., Madaio, M. P., Hayday, A. C., and Craft, J. (1996) Propagation and regulation of systemic autoimmunity by y6 T cells. J. Immunol. 157, 5689–5698.
Peng, S. L., Robert, M. E., Hayday, A. C., and Craft, J. (1996) A tumor suppressor function for fas (CD95) revealed in T-cell—deficient mice. J. Exp. Med. 184, 1149–1154.
Mombaerts, P., Clarke, A. R., Rudnicki, M. A., Iacomini, J., Itohara, S., Lafaille, J. J., Wang, L., Ichikawa, Y., Jaenisch, R., Hooper, M. L., and Tonegawa, S. (1992) Mutations in T-cell antigen receptor genes a and 13 block thymocyte development at different stages. Nature 360, 225–231.
Mombaerts, P., Mizoguchi, E., Grusby, M. J., Glimcher, L. H., Bhan, A. K., and Tonegawa, S. (1993) Spontaneous development of inflammatory bowel disease in T-cell receptor mutant mice. Cell 75, 274–282.
Zhou, T., Edwards, C. K., III, Yang, P., Wang, Z., Bluethmann, H., and Mountz, J. D. (1996) Greatly accelerated lymphadenopathy and autoimmune disease in 1pr mice lacking tumor necrosis factor receptor I. J. Immunol. 156, 2661–2665.
Peng, S., Moslehi, J., Robert, M. E., and Craft, J. (1998) Perforin protects against autoimmunity in lupus-prone mice. J. Immunol. 160, 652–660.
Nussenzweig, M. C., Schmidt, E. V., Shaw, A. C., Sinn, E., Campos-Torres, J., Mathey-Prevot, B., Pattengale, P. K., and Leder, P. (1988) A human immunoglobulin gene reduces the incidence of lymphomas in c-Myc-bearing transgenic mice. Nature 336, 446–450.
Wen, L., Roberts, S. J., Viney, J. L., Wong, F. S., Mallick, C., Findly, R. C., Peng, Q., Craft, J. E., Owen, J. J., and Hayday, A. C. (1994) Immunoglobulin synthesis and generalized autoimmunity in mice congenitally deficient in aß(+) T cells. Nature 369, 654–658.
Peng, S. L., Madaio, M. P., Hughes, D. P. M., Crispe, I. N., Owen, M. J., Wen, L., Hayday, A. C., and Craft, J. (1996) Murine lupus in the absence of af3 T cells. J. Immunol. 156, 4041–4049.
Peng, S. L., Cappadona, J., McNiff, J. M., Madaio, M. P., Owen, M. J., Hayday, A. C., and Craft, J. (1998) Pathogenesis of autoimmunity in aß T-cell—deficient lupus-prone mice. Clin. Exp. Immunol. 111, 107–116.
Peng, S. L., McNiff, J. M., Madaio, M. P., Ma, J., Owen, M. J., Flavell, R. A., Hayday, A. C., and Craft, J. (1997) a(3 T-cell regulation and CD40 ligand dependence in murine systemic autoimmunity. J. Immunol. 158, 2464–2470.
Peng, S. L., Fatenejad, S., and Craft, J. (1996) Induction of nonpathologic, humoral autoimmunity in lupus-prone mice by a class II-restricted, transgenic c43 T cell: separation of autoantigen-specific and -nonspecific help. J. Immunol. 157, 5225–5230.
Nakajima, A., Hirose, S., Yagita, H., and Okumura, K. (1997) Roles of IL-4 and IL-12 in the development of lupus in NZB/W F1 mice. J. Immunol. 158, 1466–1472.
Peng, S. L., Moslehi, J., and Craft, J. (1997) Roles of interferon-y and interleukin-4 in murine lupus. J. Clin. Invest. 99, 1936–1946.
Erb, K. J., Ruger, B., von Brevern, M., Ryffel, B., Schimpl, A., and Rivett, K. (1997) Constitutive expression of interleukin (IL)-4 in vivo causes autoimmune-type disorders in mice. J. Exp. Med. 185, 329–339.
Santiago, M. L., Fossati, L., Jacquet, C., Muller, W., Izui, S., and Reininger, L. (1997) Interleukin-4 protects against a genetically linked lupus-like autoimmune syndrome. J. Exp. Med. 185, 65–70.
Miletic, V.D., and Frank, M. M. (1995) Complement-immunoglobulin interactions. Curr. Opin. Immunol. 7, 41–47.
Wen, L., Pao, W., Wong, F. S., Peng, Q., Craft, J., Zheng, B., Kelsoe, G., Dianda, L., Owen, M. J., and Hayday, A. C. (1996) Germinal center formation, immunoglobulin class switching, and autoantibody production driven by “non a/13” T cells. J. Exp. Med. 183, 2271–2282.
Mizoguchi, A., Mizoguchi, E., Chiba, C., Spiekermann, G. M., Tonegawa, S., Nagler-Anderson, C., and Bhan, A. K. (1996) Cytokine imbalance and autoantibody production in T-cell receptor-a mutant mice with inflammatory bowel disease. J. Exp. Med. 183, 847–856.
Roth, C., Rochlitz, C., and Kourilsky, P. (1994) Immune response against tumors. Adv. Immunol. 57, 281–351.
Shivakumar, S., Tsokos, G. C., and Datta, S. K. (1989) T-cell receptor a/13 expressing double-negative (CD4-/CD8-) and CD4+ T helper cells in humans augment the production of pathogenic anti-DNA autoantibodies associated with lupus nephritis. J. Immunol. 143, 103–112.
Rajagopalan, S., Mao, C., and Datta, S. K. (1992) Pathogenic autoantibody-inducing y/8 T helper cells from patients with lupus nephritis express unusual T-cell receptors. Clin. Immunol. Immunopathol. 62, 344–350.
Chen, S.-Y., Takeoka, Y., Ansari, A., Boyd, R., Klinman, D. M., and Gershwin, M. E. (1996) The natural history of disease expression in CD4 and CD8 gene-deleted New Zealand Black (NZB) mice. J. Immunol. 157, 2676–2684.
Haas, C., Ryffel, B., and Le Hir, M. (1996) IFN-y is essential for development of autoimmune glomerulonephritis in MRL/lpr mice. J. Immunol. 158, 5484–5491.
Peng, S. L., and Craft, J. (1997) The regulation of murine lupus. Ann. N Y Acad. Sci. 815, 128–138.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer Science+Business Media New York
About this chapter
Cite this chapter
Peng, S.L., Craft, J. (1999). Lessons from Knockout and Transgenic Lupus-Prone Mice. In: Kammer, G.M., Tsokos, G.C. (eds) Lupus. Contemporary Immunology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-703-1_10
Download citation
DOI: https://doi.org/10.1007/978-1-59259-703-1_10
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-4757-5686-9
Online ISBN: 978-1-59259-703-1
eBook Packages: Springer Book Archive